BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hudson WH, Gensheimer J, Hashimoto M, Wieland A, Valanparambil RM, Li P, Lin JX, Konieczny BT, Im SJ, Freeman GJ, Leonard WJ, Kissick HT, Ahmed R. Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection. Immunity 2019;51:1043-1058.e4. [PMID: 31810882 DOI: 10.1016/j.immuni.2019.11.002] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 36.7] [Reference Citation Analysis]
Number Citing Articles
1 Di Pilato M, Kfuri-Rubens R, Pruessmann JN, Ozga AJ, Messemaker M, Cadilha BL, Sivakumar R, Cianciaruso C, Warner RD, Marangoni F, Carrizosa E, Lesch S, Billingsley J, Perez-Ramos D, Zavala F, Rheinbay E, Luster AD, Gerner MY, Kobold S, Pittet MJ, Mempel TR. CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment. Cell 2021:S0092-8674(21)00856-4. [PMID: 34343496 DOI: 10.1016/j.cell.2021.07.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Chen X, Lin Y, Yue S, Yang Y, Wang X, Pan Z, Yang X, Gao L, Zhou J, Li Z, Hu L, Tang J, Wu Q, Wang Y, Tian Q, Hao Y, Xu L, Zhu B, Huang Q, Ye L. Differential expression of inhibitory receptor NKG2A distinguishes disease‐specific exhausted CD8 + T cells. MedComm 2022;3. [DOI: 10.1002/mco2.111] [Reference Citation Analysis]
3 Maurice NJ, Berner J, Taber AK, Zehn D, Prlic M. Inflammatory signals are sufficient to elicit TOX expression in mouse and human CD8+ T cells. JCI Insight 2021;6:150744. [PMID: 34032638 DOI: 10.1172/jci.insight.150744] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Belk JA, Daniel B, Satpathy AT. Epigenetic regulation of T cell exhaustion. Nat Immunol 2022. [PMID: 35624210 DOI: 10.1038/s41590-022-01224-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Smith PL, Yogaratnam Y, Samad M, Kasow S, Dalgleish AG. Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cells. Clin Transl Oncol 2021;23:110-21. [PMID: 32661823 DOI: 10.1007/s12094-020-02429-0] [Reference Citation Analysis]
6 Xiao M, Xie L, Cao G, Lei S, Wang P, Wei Z, Luo Y, Fang J, Yang X, Huang Q, Xu L, Guo J, Wen S, Wang Z, Wu Q, Tang J, Wang L, Chen X, Chen C, Zhang Y, Yao W, Ye J, He R, Huang J, Ye L. CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy. J Immunother Cancer 2022;10:e004022. [PMID: 35580929 DOI: 10.1136/jitc-2021-004022] [Reference Citation Analysis]
7 Horton BL, Morgan DM, Momin N, Zagorulya M, Torres-Mejia E, Bhandarkar V, Wittrup KD, Love JC, Spranger S. Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non-small cell lung cancer. Sci Immunol 2021;6:eabi8800. [PMID: 34714687 DOI: 10.1126/sciimmunol.abi8800] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Barnaba V. T Cell Memory in Infection, Cancer, and Autoimmunity. Front Immunol 2021;12:811968. [PMID: 35069600 DOI: 10.3389/fimmu.2021.811968] [Reference Citation Analysis]
9 Richert-Spuhler LE, Mar CM, Shinde P, Wu F, Hong T, Greene E, Hou S, Thomas K, Gottardo R, Mugo N, de Bruyn G, Celum C, Baeten JM, Lingappa JR, Lund JM; Partners in Prevention HSV/HIV Transmission Study., and the Partners PrEP Study Teams. CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions. Cell Rep Med 2021;2:100322. [PMID: 34195685 DOI: 10.1016/j.xcrm.2021.100322] [Reference Citation Analysis]
10 Jiang W, He Y, He W, Wu G, Zhou X, Sheng Q, Zhong W, Lu Y, Ding Y, Lu Q, Ye F, Hua H. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy. Front Immunol 2020;11:622509. [PMID: 33633741 DOI: 10.3389/fimmu.2020.622509] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
11 Chen Y, Zander RA, Wu X, Schauder DM, Kasmani MY, Shen J, Zheng S, Burns R, Taparowsky EJ, Cui W. BATF regulates progenitor to cytolytic effector CD8+ T cell transition during chronic viral infection. Nat Immunol 2021;22:996-1007. [PMID: 34282329 DOI: 10.1038/s41590-021-00965-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Topchyan P, Xin G, Chen Y, Zheng S, Burns R, Shen J, Kasmani MY, Kudek M, Yang N, Cui W. Harnessing the IL-21-BATF Pathway in the CD8+ T Cell Anti-Tumor Response. Cancers (Basel) 2021;13:1263. [PMID: 33809259 DOI: 10.3390/cancers13061263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Andreatta M, Corria-Osorio J, Müller S, Cubas R, Coukos G, Carmona SJ. Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat Commun 2021;12:2965. [PMID: 34017005 DOI: 10.1038/s41467-021-23324-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Im SJ, Ha SJ. Re-defining T-Cell Exhaustion: Subset, Function, and Regulation. Immune Netw 2020;20:e2. [PMID: 32158590 DOI: 10.4110/in.2020.20.e2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
15 Johnson LR, Lee DY, Eacret JS, Ye D, June CH, Minn AJ. The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function. Cell 2021;184:4981-4995.e14. [PMID: 34464586 DOI: 10.1016/j.cell.2021.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Beltra JC, Manne S, Abdel-Hakeem MS, Kurachi M, Giles JR, Chen Z, Casella V, Ngiow SF, Khan O, Huang YJ, Yan P, Nzingha K, Xu W, Amaravadi RK, Xu X, Karakousis GC, Mitchell TC, Schuchter LM, Huang AC, Wherry EJ. Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms. Immunity 2020;52:825-841.e8. [PMID: 32396847 DOI: 10.1016/j.immuni.2020.04.014] [Cited by in Crossref: 109] [Cited by in F6Publishing: 94] [Article Influence: 54.5] [Reference Citation Analysis]
17 Sullivan PM, Reed SJ, Kalia V, Sarkar S. Solid Tumor Microenvironment Can Harbor and Support Functional Properties of Memory T Cells. Front Immunol 2021;12:706150. [DOI: 10.3389/fimmu.2021.706150] [Reference Citation Analysis]
18 Ren HM, Lukacher AE. IL-21 in Homeostasis of Resident Memory and Exhausted CD8 T Cells during Persistent Infection. Int J Mol Sci 2020;21:E6966. [PMID: 32971931 DOI: 10.3390/ijms21186966] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
19 Zhao X, Shan Q, Xue HH. TCF1 in T cell immunity: a broadened frontier. Nat Rev Immunol 2021. [PMID: 34127847 DOI: 10.1038/s41577-021-00563-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Niogret J, Berger H, Rebe C, Mary R, Ballot E, Truntzer C, Thibaudin M, Derangère V, Hibos C, Hampe L, Rageot D, Accogli T, Joubert P, Routy B, Harker J, Vegran F, Ghiringhelli F, Chalmin F. Follicular helper-T cells restore CD8+-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy. J Immunother Cancer 2021;9:e002157. [PMID: 34103351 DOI: 10.1136/jitc-2020-002157] [Reference Citation Analysis]
21 Buchholz VR, Busch DH. Back to the Future: Effector Fate during T Cell Exhaustion. Immunity 2019;51:970-2. [PMID: 31851902 DOI: 10.1016/j.immuni.2019.11.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Van Braeckel-Budimir N, Dolina JS, Wei J, Wang X, Chen SH, Santiago P, Tu G, Micci L, Al-Khami AA, Pfister S, Ram S, Sundar P, Thomas G, Long H, Yang W, Potluri S, Salek-Ardakani S. Combinatorial immunotherapy induces tumor-infiltrating CD8+ T cells with distinct functional, migratory, and stem-like properties. J Immunother Cancer 2021;9:e003614. [PMID: 34903555 DOI: 10.1136/jitc-2021-003614] [Reference Citation Analysis]
23 Labarta-Bajo L, Gramalla-Schmitz A, Gerner RR, Kazane KR, Humphrey G, Schwartz T, Sanders K, Swafford A, Knight R, Raffatellu M, Zúñiga EI. CD8 T cells drive anorexia, dysbiosis, and blooms of a commensal with immunosuppressive potential after viral infection. Proc Natl Acad Sci U S A 2020;117:24998-5007. [PMID: 32958643 DOI: 10.1073/pnas.2003656117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 [DOI: 10.1101/2020.03.19.998450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Kasmani MY, Cui W. Inhibiting BRD4 to generate BETter T cell memory. J Exp Med 2021;218:e20210877. [PMID: 34132742 DOI: 10.1084/jem.20210877] [Reference Citation Analysis]
26 Drijvers JM, Sharpe AH, Haigis MC. The effects of age and systemic metabolism on anti-tumor T cell responses. Elife 2020;9:e62420. [PMID: 33170123 DOI: 10.7554/eLife.62420] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
27 Zhou T, Damsky W, Weizman OE, McGeary MK, Hartmann KP, Rosen CE, Fischer S, Jackson R, Flavell RA, Wang J, Sanmamed MF, Bosenberg MW, Ring AM. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy. Nature 2020;583:609-14. [PMID: 32581358 DOI: 10.1038/s41586-020-2422-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 18.5] [Reference Citation Analysis]
28 Zebley CC, Brown C, Mi T, Fan Y, Alli S, Boi S, Galletti G, Lugli E, Langfitt D, Metais JY, Lockey T, Meagher M, Triplett B, Talleur AC, Gottschalk S, Youngblood B. CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia. Cell Rep 2021;37:110079. [PMID: 34852226 DOI: 10.1016/j.celrep.2021.110079] [Reference Citation Analysis]
29 Ozga AJ, Chow MT, Lopes ME, Servis RL, Di Pilato M, Dehio P, Lian J, Mempel TR, Luster AD. CXCL10 chemokine regulates heterogeneity of the CD8+ T cell response and viral set point during chronic infection. Immunity 2021:S1074-7613(21)00493-3. [PMID: 34847356 DOI: 10.1016/j.immuni.2021.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zebley CC, Youngblood B. CAR T cells need a pitstop to win the race. Cancer Cell 2021;39:756-8. [PMID: 34129822 DOI: 10.1016/j.ccell.2021.05.011] [Reference Citation Analysis]
31 Sandu I, Cerletti D, Claassen M, Oxenius A. Exhausted CD8+ T cells exhibit low and strongly inhibited TCR signaling during chronic LCMV infection. Nat Commun 2020;11:4454. [PMID: 32901001 DOI: 10.1038/s41467-020-18256-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
32 Muramatsu T, Noguchi T, Sugiyama D, Kanada Y, Fujimaki K, Ito S, Gotoh M, Nishikawa H. Newly emerged immunogenic neoantigens in established tumors enable hosts to regain immunosurveillance in a T-cell-dependent manner. Int Immunol 2021;33:39-48. [PMID: 32729901 DOI: 10.1093/intimm/dxaa049] [Reference Citation Analysis]
33 Zander R, Kasmani MY, Chen Y, Topchyan P, Shen J, Zheng S, Burns R, Ingram J, Cui C, Joshi N, Craft J, Zajac A, Cui W. Tfh-cell-derived interleukin 21 sustains effector CD8+ T cell responses during chronic viral infection. Immunity 2022:S1074-7613(22)00047-4. [PMID: 35216666 DOI: 10.1016/j.immuni.2022.01.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
34 Chen J, Song Y, Miao F, Chen G, Zhu Y, Wu N, Pang L, Chen Z, Chen X. PDL1-positive exosomes suppress antitumor immunity by inducing tumor-specific CD8+ T cell exhaustion during metastasis. Cancer Sci 2021;112:3437-54. [PMID: 34152672 DOI: 10.1111/cas.15033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Morris SR, Chen B, Mudd JC, Panigrahi S, Shive CL, Sieg SF, Cameron CM, Zidar DA, Funderburg NT, Younes SA, Rodriguez B, Gianella S, Lederman MM, Freeman ML. Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15. JCI Insight 2020;5:132963. [PMID: 32369455 DOI: 10.1172/jci.insight.132963] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
36 Warshauer JT, Belk JA, Chan AY, Wang J, Gupta AR, Shi Q, Skartsis N, Peng Y, Phipps JD, Acenas D, Smith JA, Tamaki SJ, Tang Q, Gardner JM, Satpathy AT, Anderson MS. A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance. J Exp Med 2021;218:e20210759. [PMID: 34115115 DOI: 10.1084/jem.20210759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Connolly KA, Kuchroo M, Venkat A, Khatun A, Wang J, William I, Hornick NI, Fitzgerald BL, Damo M, Kasmani MY, Cui C, Fagerberg E, Monroy I, Hutchins A, Cheung JF, Foster GG, Mariuzza DL, Nader M, Zhao H, Cui W, Krishnaswamy S, Joshi NS. A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci Immunol 2021;6:eabg7836. [PMID: 34597124 DOI: 10.1126/sciimmunol.abg7836] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
38 Borst J, Busselaar J, Bosma DMT, Ossendorp F. Mechanism of action of PD-1 receptor/ligand targeted cancer immunotherapy. Eur J Immunol 2021;51:1911-20. [PMID: 34106465 DOI: 10.1002/eji.202048994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Chan JD, Lai J, Slaney CY, Kallies A, Beavis PA, Darcy PK. Cellular networks controlling T cell persistence in adoptive cell therapy. Nat Rev Immunol 2021. [PMID: 33879873 DOI: 10.1038/s41577-021-00539-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Yermanos A, Sandu I, Pedrioli A, Borsa M, Wagen F, Oetiker N, Welten SPM, Pallmer K, Reddy ST, Oxenius A. Profiling Virus-Specific Tcf1+ T Cell Repertoires During Acute and Chronic Viral Infection. Front Immunol 2020;11:986. [PMID: 32547546 DOI: 10.3389/fimmu.2020.00986] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Osuch S, Metzner KJ, Caraballo Cortés K. Reversal of T Cell Exhaustion in Chronic HCV Infection. Viruses 2020;12:E799. [PMID: 32722372 DOI: 10.3390/v12080799] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Yao C, Lou G, Sun HW, Zhu Z, Sun Y, Chen Z, Chauss D, Moseman EA, Cheng J, D'Antonio MA, Shi W, Shi J, Kometani K, Kurosaki T, Wherry EJ, Afzali B, Gattinoni L, Zhu Y, McGavern DB, O'Shea JJ, Schwartzberg PL, Wu T. BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells. Nat Immunol 2021;22:370-80. [PMID: 33574619 DOI: 10.1038/s41590-021-00868-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
43 Wen S, Lu H, Wang D, Guo J, Dai W, Wang Z. TCF-1 maintains CD8+ T cell stemness in tumor microenvironment. J Leukoc Biol 2021;110:585-90. [PMID: 34047386 DOI: 10.1002/JLB.5MR1120-778R] [Reference Citation Analysis]
44 Pan J, Chen Y, Zhang Q, Khatun A, Palen K, Xin G, Wang L, Yang C, Johnson BD, Myers CR, Sei S, Shoemaker RH, Lubet RA, Wang Y, Cui W, You M. Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA. Commun Biol 2021;4:906. [PMID: 34302042 DOI: 10.1038/s42003-021-02381-x] [Reference Citation Analysis]
45 Wagle MV, Vervoort SJ, Kelly MJ, Van Der Byl W, Peters TJ, Martin BP, Martelotto LG, Nüssing S, Ramsbottom KM, Torpy JR, Knight D, Reading S, Thia K, Miosge LA, Howard DR, Gloury R, Gabriel SS, Utzschneider DT, Oliaro J, Powell JD, Luciani F, Trapani JA, Johnstone RW, Kallies A, Goodnow CC, Parish IA. Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance. Nat Commun 2021;12:2782. [PMID: 33986293 DOI: 10.1038/s41467-021-23044-9] [Reference Citation Analysis]
46 Sun Y, Preiss NK, Valenteros KB, Kamal Y, Usherwood YK, Frost HR, Usherwood EJ. Zbtb20 Restrains CD8 T Cell Immunometabolism and Restricts Memory Differentiation and Antitumor Immunity. J Immunol 2020;205:2649-66. [PMID: 32998985 DOI: 10.4049/jimmunol.2000459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Takata H, Trautmann L. Transforming dysfunctional CD8+ T cells into natural controller-like CD8+ T cells: can TCF-1 be the magic wand? J Clin Invest 2022;132:e160474. [PMID: 35642630 DOI: 10.1172/JCI160474] [Reference Citation Analysis]
48 Chung HK, McDonald B, Kaech SM. The architectural design of CD8+ T cell responses in acute and chronic infection: Parallel structures with divergent fates. J Exp Med 2021;218:e20201730. [PMID: 33755719 DOI: 10.1084/jem.20201730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Eberhardt CS, Kissick HT, Patel MR, Cardenas MA, Prokhnevska N, Obeng RC, Nasti TH, Griffith CC, Im SJ, Wang X, Shin DM, Carrington M, Chen ZG, Sidney J, Sette A, Saba NF, Wieland A, Ahmed R. Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer. Nature 2021;597:279-84. [PMID: 34471285 DOI: 10.1038/s41586-021-03862-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
50 Anadon CM, Yu X, Hänggi K, Biswas S, Chaurio RA, Martin A, Payne KK, Mandal G, Innamarato P, Harro CM, Mine JA, Sprenger KB, Cortina C, Powers JJ, Costich TL, Perez BA, Gatenbee CD, Prabhakaran S, Marchion D, Heemskerk MH, Curiel TJ, Anderson AR, Wenham RM, Rodriguez PC, Conejo-garcia JR. Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells. Cancer Cell 2022. [DOI: 10.1016/j.ccell.2022.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
51 Celardo I, Pace L, Cifaldi L, Gaudio C, Barnaba V. The immune system view of the coronavirus SARS-CoV-2. Biol Direct 2020;15:30. [PMID: 33371901 DOI: 10.1186/s13062-020-00283-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
52 Knuschke T, Kollenda S, Wenzek C, Zelinskyy G, Steinbach P, Dittmer U, Buer J, Epple M, Westendorf AM. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells. mBio 2021;12:e02121-20. [PMID: 33531395 DOI: 10.1128/mBio.02121-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Vera Aguilera J, Paludo J, McWilliams RR, Zhang H, Li Y, Kumar AB, Failing J, Kottschade LA, Block MS, Markovic SN, Dong H, Dronca RS, Yan Y. Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients. Melanoma Res 2020;30:364-75. [PMID: 32404734 DOI: 10.1097/CMR.0000000000000669] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
54 Stern PL, Dalianis T. Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors. Viruses 2021;13:1234. [PMID: 34202255 DOI: 10.3390/v13071234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Diggins KE, Serti E, Muir V, Rosasco M, Lu T, Balmas E, Nepom G, Long SA, Linsley PS. Exhausted-like CD8+ T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects. JCI Insight 2021;6:142680. [PMID: 33351781 DOI: 10.1172/jci.insight.142680] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
56 Escobar G, Mangani D, Anderson AC. T cell factor 1: A master regulator of the T cell response in disease. Sci Immunol 2020;5:eabb9726. [PMID: 33158974 DOI: 10.1126/sciimmunol.abb9726] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
57 Stern PL. Harnessing immunity for therapy in human papillomavirus driven cancers. Tumour Virus Res 2021;11:200212. [PMID: 33602657 DOI: 10.1016/j.tvr.2021.200212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Frias AB, Boi SK, Lan X, Youngblood B. Epigenetic regulation of T cell adaptive immunity. Immunol Rev 2021;300:9-21. [PMID: 33644866 DOI: 10.1111/imr.12943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Kuhn R, Sandu I, Agrafiotis A, Hong KL, Shlesinger D, Neimeier D, Merkler D, Oxenius A, Reddy ST, Yermanos A. Clonally Expanded Virus-Specific CD8 T Cells Acquire Diverse Transcriptional Phenotypes During Acute, Chronic, and Latent Infections. Front Immunol 2022;13:782441. [PMID: 35185882 DOI: 10.3389/fimmu.2022.782441] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Ronen D, Bsoul A, Lotem M, Abedat S, Yarkoni M, Amir O, Asleh R. Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies. Vaccines 2022;10:540. [DOI: 10.3390/vaccines10040540] [Reference Citation Analysis]
61 Chang YM, Wieland A, Li ZR, Im SJ, McGuire DJ, Kissick HT, Antia R, Ahmed R. T Cell Receptor Diversity and Lineage Relationship between Virus-Specific CD8 T Cell Subsets during Chronic Lymphocytic Choriomeningitis Virus Infection. J Virol 2020;94:e00935-20. [PMID: 32759317 DOI: 10.1128/JVI.00935-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
62 Cardenas MA, Prokhnevska N, Kissick HT. Organized immune cell interactions within tumors sustain a productive T-cell response. Int Immunol 2021;33:27-37. [PMID: 32827212 DOI: 10.1093/intimm/dxaa057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Nüssing S, Trapani JA, Parish IA. Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy. Front Immunol 2020;11:589641. [PMID: 33072137 DOI: 10.3389/fimmu.2020.589641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Schoenfeld AJ, Hellmann MD. Acquired Resistance to Immune Checkpoint Inhibitors. Cancer Cell 2020;37:443-55. [PMID: 32289269 DOI: 10.1016/j.ccell.2020.03.017] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 29.5] [Reference Citation Analysis]
65 Jaiswal A, Verma A, Dannenfelser R, Melssen M, Tirosh I, Izar B, Kim TG, Nirschl CJ, Devi KSP, Olson WC Jr, Slingluff CL Jr, Engelhard VH, Garraway L, Regev A, Minkis K, Yoon CH, Troyanskaya O, Elemento O, Suárez-Fariñas M, Anandasabapathy N. An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes. Cancer Cell 2022;40:524-544.e5. [PMID: 35537413 DOI: 10.1016/j.ccell.2022.04.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Hanna BS, Llaó-Cid L, Iskar M, Roessner PM, Klett LC, Wong JKL, Paul Y, Ioannou N, Öztürk S, Mack N, Kalter V, Colomer D, Campo E, Bloehdorn J, Stilgenbauer S, Dietrich S, Schmidt M, Gabriel R, Rippe K, Feuerer M, Ramsay AG, Lichter P, Zapatka M, Seiffert M. Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity. Immunity 2021;54:2825-2841.e10. [PMID: 34879221 DOI: 10.1016/j.immuni.2021.11.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Charmoy M, Wyss T, Delorenzi M, Held W. PD-1+ Tcf1+ CD8+ T cells from established chronic infection can form memory while retaining a stableimprint of persistent antigen exposure. Cell Rep 2021;36:109672. [PMID: 34496259 DOI: 10.1016/j.celrep.2021.109672] [Reference Citation Analysis]
68 Miller D, Gershater M, Slutsky R, Romero R, Gomez-Lopez N. Maternal and fetal T cells in term pregnancy and preterm labor. Cell Mol Immunol 2020;17:693-704. [PMID: 32467619 DOI: 10.1038/s41423-020-0471-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
69 Baharom F, Ramirez-Valdez RA, Tobin KKS, Yamane H, Dutertre CA, Khalilnezhad A, Reynoso GV, Coble VL, Lynn GM, Mulè MP, Martins AJ, Finnigan JP, Zhang XM, Hamerman JA, Bhardwaj N, Tsang JS, Hickman HD, Ginhoux F, Ishizuka AS, Seder RA. Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells. Nat Immunol 2021;22:41-52. [PMID: 33139915 DOI: 10.1038/s41590-020-00810-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
70 Conner M, Hance KW, Yadavilli S, Smothers J, Waight JD. Emergence of the CD226 Axis in Cancer Immunotherapy. Front Immunol 2022;13:914406. [DOI: 10.3389/fimmu.2022.914406] [Reference Citation Analysis]
71 Verdon DJ, Mulazzani M, Jenkins MR. Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion. Int J Mol Sci 2020;21:E7357. [PMID: 33027962 DOI: 10.3390/ijms21197357] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
72 Kim BS, Kuen DS, Koh CH, Kim HD, Chang SH, Kim S, Jeon YK, Park YJ, Choi G, Kim J, Kang KW, Kim HY, Kang SJ, Hwang S, Shin EC, Kang CY, Dong C, Chung Y. Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer. J Immunother Cancer 2021;9:e002603. [PMID: 34083422 DOI: 10.1136/jitc-2021-002603] [Reference Citation Analysis]
73 Gabriel SS, Tsui C, Chisanga D, Weber F, Llano-León M, Gubser PM, Bartholin L, Souza-Fonseca-Guimaraes F, Huntington ND, Shi W, Utzschneider DT, Kallies A. Transforming growth factor-β-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection. Immunity 2021;54:1698-1714.e5. [PMID: 34233154 DOI: 10.1016/j.immuni.2021.06.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Sandu I, Cerletti D, Oetiker N, Borsa M, Wagen F, Spadafora I, Welten SPM, Stolz U, Oxenius A, Claassen M. Landscape of Exhausted Virus-Specific CD8 T Cells in Chronic LCMV Infection. Cell Rep 2020;32:108078. [PMID: 32846135 DOI: 10.1016/j.celrep.2020.108078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
75 Labarta-Bajo L, Nilsen SP, Humphrey G, Schwartz T, Sanders K, Swafford A, Knight R, Turner JR, Zúñiga EI. Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection. J Exp Med 2020;217:e20192276. [PMID: 32880630 DOI: 10.1084/jem.20192276] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
76 McGee HM, Marciscano AE, Campbell AM, Monjazeb AM, Kaech SM, Teijaro JR. Parallels Between the Antiviral State and the Irradiated State. J Natl Cancer Inst 2021;113:969-79. [PMID: 33252657 DOI: 10.1093/jnci/djaa190] [Reference Citation Analysis]
77 Alanio C, Wherry EJ. Subsetting the subsets: Heterogeneity and developmental relationships of T cells in human tumors. Sci Immunol 2021;6:eabj3067. [PMID: 34301801 DOI: 10.1126/sciimmunol.abj3067] [Reference Citation Analysis]
78 Im SJ, Konieczny BT, Hudson WH, Masopust D, Ahmed R. PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection. Proc Natl Acad Sci U S A 2020;117:4292-9. [PMID: 32034098 DOI: 10.1073/pnas.1917298117] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
79 Kanev K, Zehn D. Origin and fine-tuning of effector CD8 T cell subpopulations in chronic infection. Curr Opin Virol 2021;46:27-35. [PMID: 33137688 DOI: 10.1016/j.coviro.2020.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Wildner NH, Walker A, Brauneck F, Ditt V, Peine S, Huber S, Haag F, Beisel C, Timm J, Schulze zur Wiesch J. Transcriptional Pattern Analysis of Virus-Specific CD8+ T Cells in Hepatitis C Infection: Increased Expression of TOX and Eomesodermin During and After Persistent Antigen Recognition. Front Immunol 2022;13:886646. [DOI: 10.3389/fimmu.2022.886646] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Burger ML, Cruz AM, Crossland GE, Gaglia G, Ritch CC, Blatt SE, Bhutkar A, Canner D, Kienka T, Tavana SZ, Barandiaran AL, Garmilla A, Schenkel JM, Hillman M, de Los Rios Kobara I, Li A, Jaeger AM, Hwang WL, Westcott PMK, Manos MP, Holovatska MM, Hodi FS, Regev A, Santagata S, Jacks T. Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors. Cell 2021;184:4996-5014.e26. [PMID: 34534464 DOI: 10.1016/j.cell.2021.08.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
82 Gueguen P, Metoikidou C, Dupic T, Lawand M, Goudot C, Baulande S, Lameiras S, Lantz O, Girard N, Seguin-Givelet A, Lefevre M, Mora T, Walczak AM, Waterfall JJ, Amigorena S. Contribution of resident and circulating precursors to tumor-infiltrating CD8+ T cell populations in lung cancer. Sci Immunol 2021;6:eabd5778. [PMID: 33514641 DOI: 10.1126/sciimmunol.abd5778] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
83 Giles JR, Manne S, Freilich E, Oldridge DA, Baxter AE, George S, Chen Z, Huang H, Chilukuri L, Carberry M, Giles L, Weng NP, Young RM, June CH, Schuchter LM, Amaravadi RK, Xu X, Karakousis GC, Mitchell TC, Huang AC, Shi J, Wherry EJ. Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers. Immunity 2022;55:557-574.e7. [PMID: 35263570 DOI: 10.1016/j.immuni.2022.02.004] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Zhang J, Lyu T, Cao Y, Feng H. Role of TCF-1 in differentiation, exhaustion, and memory of CD8+ T cells: A review. FASEB J 2021;35:e21549. [PMID: 33913198 DOI: 10.1096/fj.202002566R] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Zebley CC, Gottschalk S, Youngblood B. Rewriting History: Epigenetic Reprogramming of CD8+ T Cell Differentiation to Enhance Immunotherapy. Trends Immunol 2020;41:665-75. [PMID: 32624330 DOI: 10.1016/j.it.2020.06.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
86 Sanjabi S, Lear S. New cytometry tools for immune monitoring during cancer immunotherapy. Cytometry B Clin Cytom 2021;100:10-8. [PMID: 33432667 DOI: 10.1002/cyto.b.21984] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
87 Ciecko AE, Schauder DM, Foda B, Petrova G, Kasmani MY, Burns R, Lin CW, Drobyski WR, Cui W, Chen YG. Self-Renewing Islet TCF1+ CD8 T Cells Undergo IL-27-Controlled Differentiation to Become TCF1- Terminal Effectors during the Progression of Type 1 Diabetes. J Immunol 2021;207:1990-2004. [PMID: 34507949 DOI: 10.4049/jimmunol.2100362] [Reference Citation Analysis]
88 Desharnais L, Walsh LA, Quail DF. Exploiting the obesity-associated immune microenvironment for cancer therapeutics. Pharmacol Ther 2021;:107923. [PMID: 34171329 DOI: 10.1016/j.pharmthera.2021.107923] [Reference Citation Analysis]
89 Liu X, Zhang Y, Wang Z, Liu L, Zhang G, Li J, Ren Z, Dong Z, Yu Z. PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration. J Hepatocell Carcinoma 2021;8:1495-511. [PMID: 34881207 DOI: 10.2147/JHC.S337111] [Reference Citation Analysis]
90 Hill M, Segovia M, Russo S, Girotti MR, Rabinovich GA. The Paradoxical Roles of Inflammation during PD-1 Blockade in Cancer. Trends in Immunology 2020;41:982-93. [DOI: 10.1016/j.it.2020.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
91 Tooley KA, Escobar G, Anderson AC. Spatial determinants of CD8+ T cell differentiation in cancer. Trends in Cancer 2022. [DOI: 10.1016/j.trecan.2022.04.003] [Reference Citation Analysis]
92 Yang R, Sun L, Li CF, Wang YH, Yao J, Li H, Yan M, Chang WC, Hsu JM, Cha JH, Hsu JL, Chou CW, Sun X, Deng Y, Chou CK, Yu D, Hung MC. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat Commun 2021;12:832. [PMID: 33547304 DOI: 10.1038/s41467-021-21099-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
93 Montacchiesi G, Pace L. Epigenetics and CD8+ T cell memory. Immunol Rev 2021. [PMID: 34923638 DOI: 10.1111/imr.13057] [Reference Citation Analysis]
94 Busselaar J, Tian S, van Eenennaam H, Borst J. Helpless Priming Sends CD8+ T Cells on the Road to Exhaustion. Front Immunol 2020;11:592569. [PMID: 33123174 DOI: 10.3389/fimmu.2020.592569] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
95 Pauken KE, Torchia JA, Chaudhri A, Sharpe AH, Freeman GJ. Emerging concepts in PD-1 checkpoint biology. Semin Immunol 2021;:101480. [PMID: 34006473 DOI: 10.1016/j.smim.2021.101480] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
96 Braun DA, Street K, Burke KP, Cookmeyer DL, Denize T, Pedersen CB, Gohil SH, Schindler N, Pomerance L, Hirsch L, Bakouny Z, Hou Y, Forman J, Huang T, Li S, Cui A, Keskin DB, Steinharter J, Bouchard G, Sun M, Pimenta EM, Xu W, Mahoney KM, McGregor BA, Hirsch MS, Chang SL, Livak KJ, McDermott DF, Shukla SA, Olsen LR, Signoretti S, Sharpe AH, Irizarry RA, Choueiri TK, Wu CJ. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. Cancer Cell 2021;39:632-648.e8. [PMID: 33711273 DOI: 10.1016/j.ccell.2021.02.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
97 Kanev K, Roelli P, Wu M, Wurmser C, Delorenzi M, Pfaffl MW, Zehn D. Tailoring the resolution of single-cell RNA sequencing for primary cytotoxic T cells. Nat Commun 2021;12:569. [PMID: 33495472 DOI: 10.1038/s41467-020-20751-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Chen C, Liu Y, Cui B. Effect of radiotherapy on T cell and PD-1 / PD-L1 blocking therapy in tumor microenvironment. Hum Vaccin Immunother 2021;17:1555-67. [PMID: 33428533 DOI: 10.1080/21645515.2020.1840254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
99 He MX, Cuoco MS, Crowdis J, Bosma-Moody A, Zhang Z, Bi K, Kanodia A, Su MJ, Ku SY, Garcia MM, Sweet AR, Rodman C, DelloStritto L, Silver R, Steinharter J, Shah P, Izar B, Walk NC, Burke KP, Bakouny Z, Tewari AK, Liu D, Camp SY, Vokes NI, Salari K, Park J, Vigneau S, Fong L, Russo JW, Yuan X, Balk SP, Beltran H, Rozenblatt-Rosen O, Regev A, Rotem A, Taplin ME, Van Allen EM. Transcriptional mediators of treatment resistance in lethal prostate cancer. Nat Med 2021;27:426-33. [PMID: 33664492 DOI: 10.1038/s41591-021-01244-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
100 Li Y, Zhang Y, Cao G, Zheng X, Sun C, Wei H, Tian Z, Xiao W, Sun R, Sun H. Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors. J Hematol Oncol 2021;14. [DOI: 10.1186/s13045-021-01112-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 McLane LM, Ngiow SF, Chen Z, Attanasio J, Manne S, Ruthel G, Wu JE, Staupe RP, Xu W, Amaravadi RK, Xu X, Karakousis GC, Mitchell TC, Schuchter LM, Huang AC, Freedman BD, Betts MR, Wherry EJ. Role of nuclear localization in the regulation and function of T-bet and Eomes in exhausted CD8 T cells. Cell Rep 2021;35:109120. [PMID: 33979613 DOI: 10.1016/j.celrep.2021.109120] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
102 Cheng H, Ma K, Zhang L, Li G. The tumor microenvironment shapes the molecular characteristics of exhausted CD8+ T cells. Cancer Lett 2021;506:55-66. [PMID: 33662493 DOI: 10.1016/j.canlet.2021.02.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
103 Hossain MA, Liu G, Dai B, Si Y, Yang Q, Wazir J, Birnbaumer L, Yang Y. Reinvigorating exhausted CD8+ cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy. Med Res Rev 2021;41:156-201. [PMID: 32844499 DOI: 10.1002/med.21727] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
104 Maurer MF, Lewis KE, Kuijper JL, Ardourel D, Gudgeon CJ, Chandrasekaran S, Mudri SL, Kleist KN, Navas C, Wolfson MF, Rixon MW, Swanson R, Dillon SR, Levin SD, Kimbung YR, Akutsu M, Logan DT, Walse B, Swiderek KM, Peng SL. The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-29286-5] [Reference Citation Analysis]
105 Behrens G, Edelmann SL, Raj T, Kronbeck N, Monecke T, Davydova E, Wong EH, Kifinger L, Giesert F, Kirmaier ME, Hohn C, de Jonge LS, Pisfil MG, Fu M, Theurich S, Feske S, Kawakami N, Wurst W, Niessing D, Heissmeyer V. Disrupting Roquin-1 interaction with Regnase-1 induces autoimmunity and enhances antitumor responses. Nat Immunol 2021;22:1563-76. [PMID: 34811541 DOI: 10.1038/s41590-021-01064-3] [Reference Citation Analysis]
106 Schnell A, Huang L, Singer M, Singaraju A, Barilla RM, Regan BML, Bollhagen A, Thakore PI, Dionne D, Delorey TM, Pawlak M, Meyer Zu Horste G, Rozenblatt-Rosen O, Irizarry RA, Regev A, Kuchroo VK. Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity. Cell 2021;184:6281-6298.e23. [PMID: 34875227 DOI: 10.1016/j.cell.2021.11.018] [Reference Citation Analysis]
107 Molodtsov AK, Khatwani N, Vella JL, Lewis KA, Zhao Y, Han J, Sullivan DE, Searles TG, Preiss NK, Shabaneh TB, Zhang P, Hawkes AR, Malik BT, Kolling FW 4th, Usherwood EJ, Wong SL, Phillips JD, Shirai K, Angeles CV, Yan S, Curiel TJ, Huang YH, Cheng C, Turk MJ. Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma. Immunity 2021;54:2117-2132.e7. [PMID: 34525340 DOI: 10.1016/j.immuni.2021.08.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Kudo-Saito C, Ozaki Y, Imazeki H, Hayashi H, Masuda J, Ozawa H, Ogiwara Y. Targeting Oncoimmune Drivers of Cancer Metastasis. Cancers (Basel) 2021;13:554. [PMID: 33535613 DOI: 10.3390/cancers13030554] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
109 Trefzer A, Kadam P, Wang SH, Pennavaria S, Lober B, Akçabozan B, Kranich J, Brocker T, Nakano N, Irmler M, Beckers J, Straub T, Obst R. Dynamic adoption of anergy by antigen-exhausted CD4+ T cells. Cell Rep 2021;34:108748. [PMID: 33567282 DOI: 10.1016/j.celrep.2021.108748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Chen SH, Dominik PK, Stanfield J, Ding S, Yang W, Kurd N, Llewellyn R, Heyen J, Wang C, Melton Z, Van Blarcom T, Lindquist KC, Chaparro-Riggers J, Salek-Ardakani S. Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity. J Immunother Cancer 2021;9:e003464. [PMID: 34599020 DOI: 10.1136/jitc-2021-003464] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Dolina JS, Van Braeckel-Budimir N, Thomas GD, Salek-Ardakani S. CD8+ T Cell Exhaustion in Cancer. Front Immunol 2021;12:715234. [PMID: 34354714 DOI: 10.3389/fimmu.2021.715234] [Reference Citation Analysis]
112 Ross JL, Chen Z, Herting CJ, Grabovska Y, Szulzewsky F, Puigdelloses M, Monterroza L, Switchenko J, Wadhwani NR, Cimino PJ, Mackay A, Jones C, Read RD, MacDonald TJ, Schniederjan M, Becher OJ, Hambardzumyan D. Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma. Brain 2021;144:53-69. [PMID: 33300045 DOI: 10.1093/brain/awaa382] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
113 Collier JL, Weiss SA, Pauken KE, Sen DR, Sharpe AH. Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity. Nat Immunol 2021;22:809-19. [PMID: 34140679 DOI: 10.1038/s41590-021-00949-7] [Reference Citation Analysis]
114 Hu H, Zakharov PN, Peterson OJ, Unanue ER. Cytocidal macrophages in symbiosis with CD4 and CD8 T cells cause acute diabetes following checkpoint blockade of PD-1 in NOD mice. Proc Natl Acad Sci U S A 2020;117:31319-30. [PMID: 33229539 DOI: 10.1073/pnas.2019743117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
115 Studstill CJ, Hahm B. Chronic LCMV Infection Is Fortified with Versatile Tactics to Suppress Host T Cell Immunity and Establish Viral Persistence. Viruses 2021;13:1951. [PMID: 34696381 DOI: 10.3390/v13101951] [Reference Citation Analysis]
116 Utzschneider DT, Gabriel SS, Chisanga D, Gloury R, Gubser PM, Vasanthakumar A, Shi W, Kallies A. Early precursor T cells establish and propagate T cell exhaustion in chronic infection. Nat Immunol. 2020;21:1256-1266. [PMID: 32839610 DOI: 10.1038/s41590-020-0760-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
117 Calagua C, Ficial M, Jansen CS, Hirz T, Del Balzo L, Wilkinson S, Lake R, Ku AT, Voznesensky O, Sykes DB, Saylor PJ, Ye H, Signoretti S, Kissick H, Sowalsky AG, Balk SP, Einstein DJ. A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes. Clin Cancer Res 2021;27:4836-47. [PMID: 34168052 DOI: 10.1158/1078-0432.CCR-21-0121] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Korman AJ, Garrett-Thomson SC, Lonberg N. The foundations of immune checkpoint blockade and the ipilimumab approval decennial. Nat Rev Drug Discov 2021. [PMID: 34937915 DOI: 10.1038/s41573-021-00345-8] [Reference Citation Analysis]
119 Kujur W, Murillo O, Adduri RSR, Vankayalapati R, Konduru NV, Mulik S. Memory like NK cells display stem cell like properties after Zika virus infection. PLoS Pathog 2020;16:e1009132. [PMID: 33370392 DOI: 10.1371/journal.ppat.1009132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Tan W, Chen N, Qiu Y, Feng X, Li S, Zhang Y, Li H, Gao J, Zhao D. Exosomal Dvl3 promoted the aggressive phenotypic transformation of RA-FLS via wnt pathway. Autoimmunity 2022;:1-9. [PMID: 35499309 DOI: 10.1080/08916934.2022.2067984] [Reference Citation Analysis]
121 You G, Lee Y, Kang YW, Park HW, Park K, Kim H, Kim YM, Kim S, Kim JH, Moon D, Chung H, Son W, Jung UJ, Park E, Lee S, Son YG, Eom J, Won J, Park Y, Jung J, Lee SW. B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes. Sci Adv 2021;7:eaax3160. [PMID: 33523913 DOI: 10.1126/sciadv.aax3160] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
122 Jung S, Baek JH. The Potential of T Cell Factor 1 in Sustaining CD8+ T Lymphocyte-Directed Anti-Tumor Immunity. Cancers (Basel) 2021;13:515. [PMID: 33572793 DOI: 10.3390/cancers13030515] [Reference Citation Analysis]
123 Weisshaar N, Wu J, Ming Y, Madi A, Hotz-Wagenblatt A, Ma S, Mieg A, Hering M, Zettl F, Mohr K, Schlimbach T, Ten Bosch N, Hertel F, Müller L, Byren H, Wang M, Borgers H, Munz M, Schmitt L, van der Hoeven F, Kloz U, Carretero R, Schleußner N, Jackstadt RF, Hofmann I, Cui G. Rgs16 promotes antitumor CD8+ T cell exhaustion. Sci Immunol 2022;7:eabh1873. [PMID: 35622904 DOI: 10.1126/sciimmunol.abh1873] [Reference Citation Analysis]
124 Abdel-Hakeem MS, Manne S, Beltra JC, Stelekati E, Chen Z, Nzingha K, Ali MA, Johnson JL, Giles JR, Mathew D, Greenplate AR, Vahedi G, Wherry EJ. Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation. Nat Immunol 2021;22:1008-19. [PMID: 34312545 DOI: 10.1038/s41590-021-00975-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
125 Takamura S. Impact of multiple hits with cognate antigen on memory CD8+ T-cell fate. Int Immunol 2020;32:571-81. [PMID: 32506114 DOI: 10.1093/intimm/dxaa039] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Yamauchi T, Hoki T, Oba T, Saito H, Attwood K, Sabel MS, Chang AE, Odunsi K, Ito F. CX3CR1-CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment. JCI Insight 2020;5:133920. [PMID: 32255766 DOI: 10.1172/jci.insight.133920] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
127 Zebley CC, Youngblood B. Mechanisms of T cell exhaustion guiding next-generation immunotherapy. Trends in Cancer 2022. [DOI: 10.1016/j.trecan.2022.04.004] [Reference Citation Analysis]
128 Dähling S, Mansilla AM, Knöpper K, Grafen A, Utzschneider DT, Ugur M, Whitney PG, Bachem A, Arampatzi P, Imdahl F, Kaisho T, Zehn D, Klauschen F, Garbi N, Kallies A, Saliba AE, Gasteiger G, Bedoui S, Kastenmüller W. Type 1 conventional dendritic cells maintain and guide the differentiation of precursors of exhausted T cells in distinct cellular niches. Immunity 2022:S1074-7613(22)00129-7. [PMID: 35366396 DOI: 10.1016/j.immuni.2022.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
129 Liu B, Hu X, Feng K, Gao R, Xue Z, Zhang S, Zhang Y, Corse E, Hu Y, Han W, Zhang Z. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat Cancer 2022;3:108-21. [PMID: 35121991 DOI: 10.1038/s43018-021-00292-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]